[HTML][HTML] KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease
PE Stevens, SB Ahmed, JJ Carrero… - Kidney …, 2024 - kidney-international.org
This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …
Methods for Economic Evaluations of Novel Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review
Y Li, P Chen, X Wang, Q Peng, S Xu, A Ma… - Applied Health Economics …, 2024 - Springer
Background Atrial fibrillation (AF) is a severe epidemiological and public health concern
among the elderly population worldwide, with substantial economic and social burdens …
among the elderly population worldwide, with substantial economic and social burdens …
[HTML][HTML] Long-term cost-utility analysis of remote monitoring of older patients with pacemakers: The PONIENTE study
RJ Bautista-Mesa, A Lopez-Villegas, S Peiro… - BMC geriatrics, 2020 - Springer
Background Cost-effectiveness studies on pacemakers have increased in the last years.
However the number of long-term cost-utility studies is limited. The objective of this study …
However the number of long-term cost-utility studies is limited. The objective of this study …
[PDF][PDF] Apixaban ultrafine O/W nano emulsion transdermal drug delivery system: formulation, in vitro and ex vivo characterization
MR Abdulbaqi, NA Rajab - Systematic Reviews in Pharmacy, 2020 - researchgate.net
Apixaban (APX) is a potent oral anticoagulant drug that directly inhibit coagulation factor Xa
for prevention of venous thromboembolism (VTE) following total hip or knee replacement …
for prevention of venous thromboembolism (VTE) following total hip or knee replacement …
[HTML][HTML] Influence of renal insufficiency on anticoagulant effects and safety of warfarin in Chinese patients: Analysis from a randomized controlled trial
X Ning, Y Kuang, G Yang, J Xie, D Miao, C Guo… - Naunyn-schmiedeberg's …, 2021 - Springer
This study aimed to analyze the influence of renal insufficiency on the anticoagulant effects
and safety of warfarin in Chinese patients. Data on the creatinine levels of participants …
and safety of warfarin in Chinese patients. Data on the creatinine levels of participants …
Возможности терапевтического воздействия и профилактики цереброваскулярных осложнений при фибрилляции предсердий у больных, находящихся на …
ИТ Муркамилов, ИС Сабиров, ВВ Фомин… - Клиническая …, 2019 - elibrary.ru
Статья посвящена актуальной междисциплинарной проблеме-фибрилляции
предсердий (ФП) и риску цереброваскулярных осложнений (ЦВО) у больных …
предсердий (ФП) и риску цереброваскулярных осложнений (ЦВО) у больных …
[HTML][HTML] 慢性肾脏病患者口服抗凝药物临床应用的研究进展
杨富蓉， 钱懿轶， 周晓倩， 杨松烨， 陈韦兆… - Advances in Clinical …, 2023 - hanspub.org
慢性肾脏病(chronic kidney disease, CKD) 已然成为一个全球公认的公共卫生问题,
普遍认为CKD 和心脑血管疾病(cerebrovascular disease, CVD) 会互相影响彼此相关的结局 …
普遍认为CKD 和心脑血管疾病(cerebrovascular disease, CVD) 会互相影响彼此相关的结局 …
Cost‐effectiveness of rivaroxaban versus warfarin in non‐valvular atrial fibrillation patients with chronic kidney disease in China
L Liu, D Hong, K Ma, X Lu - Journal of Clinical Pharmacy and …, 2021 - Wiley Online Library
What is known and objective In non‐valvular atrial fibrillation (NVAF) patients with chronic
kidney disease (CKD), rivaroxaban was not inferior to warfarin in preventing stroke and …
kidney disease (CKD), rivaroxaban was not inferior to warfarin in preventing stroke and …
[PDF][PDF] Дослідити доцільність включення препаратів НОАК (нових оральний антикоагулянтів) у програму реімбурсації ліків в Україні з допомогою інструментів …
Я Кондрацький - 2023 - ekmair.ukma.edu.ua
Міністерство освіти і науки України Національний університет «Києво- Page 1
Міністерство освіти і науки України Національний університет «Києво-Могилянська …
Міністерство освіти і науки України Національний університет «Києво-Могилянська …
Aho bidezko antikoagulatzaile zuzenen maneiua fibrilazio aurikular ez-balbularra eta giltzurrun gutxiegitasun kronikoa duten pazienteengan
H Bollar Eiguren - 2021 - addi.ehu.es
[EUS] Sarrera: Giltzurrun gutxiegitasun kronikoa (GGK) duten pazienteengan fibrilazio
aurikular ez-balbularraren (FAEB) prebalentzia oso esanguratsua da. FAEBean aho …
aurikular ez-balbularraren (FAEB) prebalentzia oso esanguratsua da. FAEBean aho …